Cargando…
Plasma Metabolome Signature Indicative of BRCA1 Germline Status Independent of Cancer Incidence
Individuals carrying a pathogenic germline variant in the breast cancer predisposition gene BRCA1 (gBRCA1+) are prone to developing breast cancer. Apart from its well-known role in DNA repair, BRCA1 has been shown to powerfully impact cellular metabolism. While, in general, metabolic reprogramming w...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8058469/ https://www.ncbi.nlm.nih.gov/pubmed/33898308 http://dx.doi.org/10.3389/fonc.2021.627217 |
_version_ | 1783681020425404416 |
---|---|
author | Penkert, Judith Märtens, Andre Seifert, Martin Auber, Bernd Derlin, Katja Hille-Betz, Ursula Hörmann, Philipp Klopp, Norman Prokein, Jana Schlicker, Lisa Wacker, Frank Wallaschek, Hannah Schlegelberger, Brigitte Hiller, Karsten Ripperger, Tim Illig, Thomas |
author_facet | Penkert, Judith Märtens, Andre Seifert, Martin Auber, Bernd Derlin, Katja Hille-Betz, Ursula Hörmann, Philipp Klopp, Norman Prokein, Jana Schlicker, Lisa Wacker, Frank Wallaschek, Hannah Schlegelberger, Brigitte Hiller, Karsten Ripperger, Tim Illig, Thomas |
author_sort | Penkert, Judith |
collection | PubMed |
description | Individuals carrying a pathogenic germline variant in the breast cancer predisposition gene BRCA1 (gBRCA1+) are prone to developing breast cancer. Apart from its well-known role in DNA repair, BRCA1 has been shown to powerfully impact cellular metabolism. While, in general, metabolic reprogramming was named a hallmark of cancer, disrupted metabolism has also been suggested to drive cancer cell evolution and malignant transformation by critically altering microenvironmental tissue integrity. Systemic metabolic effects induced by germline variants in cancer predisposition genes have been demonstrated before. Whether or not systemic metabolic alterations exist in gBRCA1+ individuals independent of cancer incidence has not been investigated yet. We therefore profiled the plasma metabolome of 72 gBRCA1+ women and 72 age-matched female controls, none of whom (carriers and non-carriers) had a prior cancer diagnosis and all of whom were cancer-free during the follow-up period. We detected one single metabolite, pyruvate, and two metabolite ratios involving pyruvate, lactate, and a metabolite of yet unknown structure, significantly altered between the two cohorts. A machine learning signature of metabolite ratios was able to correctly distinguish between gBRCA1+ and controls in ~82%. The results of this study point to innate systemic metabolic differences in gBRCA1+ women independent of cancer incidence and raise the question as to whether or not constitutional alterations in energy metabolism may be involved in the etiology of BRCA1-associated breast cancer. |
format | Online Article Text |
id | pubmed-8058469 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-80584692021-04-22 Plasma Metabolome Signature Indicative of BRCA1 Germline Status Independent of Cancer Incidence Penkert, Judith Märtens, Andre Seifert, Martin Auber, Bernd Derlin, Katja Hille-Betz, Ursula Hörmann, Philipp Klopp, Norman Prokein, Jana Schlicker, Lisa Wacker, Frank Wallaschek, Hannah Schlegelberger, Brigitte Hiller, Karsten Ripperger, Tim Illig, Thomas Front Oncol Oncology Individuals carrying a pathogenic germline variant in the breast cancer predisposition gene BRCA1 (gBRCA1+) are prone to developing breast cancer. Apart from its well-known role in DNA repair, BRCA1 has been shown to powerfully impact cellular metabolism. While, in general, metabolic reprogramming was named a hallmark of cancer, disrupted metabolism has also been suggested to drive cancer cell evolution and malignant transformation by critically altering microenvironmental tissue integrity. Systemic metabolic effects induced by germline variants in cancer predisposition genes have been demonstrated before. Whether or not systemic metabolic alterations exist in gBRCA1+ individuals independent of cancer incidence has not been investigated yet. We therefore profiled the plasma metabolome of 72 gBRCA1+ women and 72 age-matched female controls, none of whom (carriers and non-carriers) had a prior cancer diagnosis and all of whom were cancer-free during the follow-up period. We detected one single metabolite, pyruvate, and two metabolite ratios involving pyruvate, lactate, and a metabolite of yet unknown structure, significantly altered between the two cohorts. A machine learning signature of metabolite ratios was able to correctly distinguish between gBRCA1+ and controls in ~82%. The results of this study point to innate systemic metabolic differences in gBRCA1+ women independent of cancer incidence and raise the question as to whether or not constitutional alterations in energy metabolism may be involved in the etiology of BRCA1-associated breast cancer. Frontiers Media S.A. 2021-04-07 /pmc/articles/PMC8058469/ /pubmed/33898308 http://dx.doi.org/10.3389/fonc.2021.627217 Text en Copyright © 2021 Penkert, Märtens, Seifert, Auber, Derlin, Hille-Betz, Hörmann, Klopp, Prokein, Schlicker, Wacker, Wallaschek, Schlegelberger, Hiller, Ripperger and Illig https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Penkert, Judith Märtens, Andre Seifert, Martin Auber, Bernd Derlin, Katja Hille-Betz, Ursula Hörmann, Philipp Klopp, Norman Prokein, Jana Schlicker, Lisa Wacker, Frank Wallaschek, Hannah Schlegelberger, Brigitte Hiller, Karsten Ripperger, Tim Illig, Thomas Plasma Metabolome Signature Indicative of BRCA1 Germline Status Independent of Cancer Incidence |
title | Plasma Metabolome Signature Indicative of BRCA1 Germline Status Independent of Cancer Incidence |
title_full | Plasma Metabolome Signature Indicative of BRCA1 Germline Status Independent of Cancer Incidence |
title_fullStr | Plasma Metabolome Signature Indicative of BRCA1 Germline Status Independent of Cancer Incidence |
title_full_unstemmed | Plasma Metabolome Signature Indicative of BRCA1 Germline Status Independent of Cancer Incidence |
title_short | Plasma Metabolome Signature Indicative of BRCA1 Germline Status Independent of Cancer Incidence |
title_sort | plasma metabolome signature indicative of brca1 germline status independent of cancer incidence |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8058469/ https://www.ncbi.nlm.nih.gov/pubmed/33898308 http://dx.doi.org/10.3389/fonc.2021.627217 |
work_keys_str_mv | AT penkertjudith plasmametabolomesignatureindicativeofbrca1germlinestatusindependentofcancerincidence AT martensandre plasmametabolomesignatureindicativeofbrca1germlinestatusindependentofcancerincidence AT seifertmartin plasmametabolomesignatureindicativeofbrca1germlinestatusindependentofcancerincidence AT auberbernd plasmametabolomesignatureindicativeofbrca1germlinestatusindependentofcancerincidence AT derlinkatja plasmametabolomesignatureindicativeofbrca1germlinestatusindependentofcancerincidence AT hillebetzursula plasmametabolomesignatureindicativeofbrca1germlinestatusindependentofcancerincidence AT hormannphilipp plasmametabolomesignatureindicativeofbrca1germlinestatusindependentofcancerincidence AT kloppnorman plasmametabolomesignatureindicativeofbrca1germlinestatusindependentofcancerincidence AT prokeinjana plasmametabolomesignatureindicativeofbrca1germlinestatusindependentofcancerincidence AT schlickerlisa plasmametabolomesignatureindicativeofbrca1germlinestatusindependentofcancerincidence AT wackerfrank plasmametabolomesignatureindicativeofbrca1germlinestatusindependentofcancerincidence AT wallaschekhannah plasmametabolomesignatureindicativeofbrca1germlinestatusindependentofcancerincidence AT schlegelbergerbrigitte plasmametabolomesignatureindicativeofbrca1germlinestatusindependentofcancerincidence AT hillerkarsten plasmametabolomesignatureindicativeofbrca1germlinestatusindependentofcancerincidence AT rippergertim plasmametabolomesignatureindicativeofbrca1germlinestatusindependentofcancerincidence AT illigthomas plasmametabolomesignatureindicativeofbrca1germlinestatusindependentofcancerincidence |